CAS 34084-50-9
:7-Aminoflunitrazepam
- 2H-1,4-Benzodiazepin-2-one, 7-amino-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-
- 2H-1,4-benzodiazepin-2-one, 7-amino-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-
- 7-Amino-1,3-dihydro-5-(2-fluorophenyl)-1-methyl-2H-1,4-benzodiazpin-2-one
- 7-Amino-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one
- 7-Aminoflunitrazepam
- Ro 20-1815
7-Aminoflunitrazepam, 1mg/ml in Acetonitrile
CAS:Kontrolliertes ProduktFarbe und Form:Single Solution7-Aminoflunitrazepam 0.1 mg/ml in Acetonitrile
CAS:Kontrolliertes ProduktFarbe und Form:Single Solution7-Aminoflunitrazepam 1.0 mg/ml in Acetonitrile
CAS:Kontrolliertes ProduktFarbe und Form:Single Solution7-Amino Flunitrazepam
CAS:Kontrolliertes ProduktFormel:C16H14FN3OFarbe und Form:NeatMolekulargewicht:283.307-Aminoflunitrazepam
CAS:Kontrolliertes Produkt7-Aminoflunitrazepam is an active metabolite of flunitrazepam and a benzodiazepine. It can be detected in urine samples using an on-line LC-MS/MS method. The detection time of 7-aminoflunitrazepam is between 3 to 4 hours, which is longer than that of its parent drug, flunitrazepam. The use of monoclonal antibodies specific for fluoroquinolones allows the detection of 7-aminoflunitrazepam with high sensitivity and specificity. This method can be used to detect the presence of flunitrazepam in human serum samples, as well as in femoral vein blood samples, urine samples, and blood sputum samples. Solid phase microextraction (SPME) was used as the sample preparation technique for this study. SPME also allows for the extraction and analysis of lysine residues from protein matrices such as human serum.
Formel:C16H14FN3OReinheit:Min. 98%Farbe und Form:PowderMolekulargewicht:283.3 g/mol


